Job Opportunities API

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role:   Reporting to the Director of SEC Reporting, the Senior Analyst will be an integral member of the Accounting team. This role will be focused on assisting with SEC reporting and month-end close activities.     Role and Responsibilities:   Assist with the preparation of supporting schedules for form 10-Q, 10-K, and proxy   Perform tie out of form 10-K and 10-Q   Assist with tracking and recording clinical trial and research-related expenses, including vendor accruals and study-related costs   Prepare and post journal entries, including accruals and other standard closing entries   Assist with internal and external auditor requests   Participate in process improvements, financial system implementations and/or enhancements   Assist with ad hoc projects as needed   All other duties as assigned     Experience, Education and Specialized Knowledge and Skills:   Minimum bachelor's degree in accounting   Minimum 4+ years of experience in accounting   Results-oriented, strong organizational skills, and time management skills with ability to multi-task   A team player willing to step in and help with other areas of accounting   Excellent analytical, interpersonal, verbal, and written communication skills   Superb analytical, strategic, and critical thinking skills, with impeccable attention to detail, and strong prioritization and problem-solving skills   Demonstrated ability to operate in a fast-paced environment   Attention to detail, accuracy and confidentiality   Excellent organizational, management, analytical & decision-making skills   An ability to work well cross functionally and across geographies